News
HHS further constrains certain vaccine advisers to the CDC, limiting their input in evidence reviews
In a further jolt to the process of reviewing and recommending vaccines at the US Centers for Disease Control and Prevention, ...
U.S. President Donald Trump's administration is blocking funding for a swath of public-health programs run by the Centers for ...
The US Centers for Disease Control and Prevention told physician groups, public health professionals and infectious disease experts that they will no longer be invited to help review vaccine data and ...
The U.S. Centers for Disease Control and Prevention told physician groups, public health professionals and infectious disease experts that they will no longer be invited to help review vaccine data ...
Dr. Susan Monarez was sworn in Thursday as director of the US Centers for Disease Control and Prevention, and she’s taking ...
Strong performance and sales acceleration with total net sales of CHF 58 million in H1 2025 and increase of 145% compared to ...
Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...
Merck did not immediately respond to a request for comment on the job cuts. The company expects the program to cost about $3 billion to implement but would lead to $3 billion in annual cost savings by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results